← all works
Retraction Note: MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Post-publication record
OpenAlex flags this work as retracted, but it carries no matching Retraction Watch record in this frame.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- Psychopharmacology
- Topic
- Tryptophan and brain disorders
- Field
- Neuroscience
- Canadian institutions
- Okanagan University CollegeUniversity of British Columbia, Okanagan CampusUniversity of British Columbia
- Funders
- —
- Keywords
- MDMARandomized controlled trialPsychotherapistPsychologyPsychiatryClinical psychologyMedicineInternal medicine
- Has abstract in OpenAlex
- no